[Denver, 4 July 2025] – Clearview Market Insights (CVMI) projects that the global CBD hemp oil market will increase from USD 7.68 billion in 2024 to USD 18.37 billion by 2031, growing at a CAGR of 13.2%. Rising demand for plant-based wellness products, increasing mainstream acceptance of CBD, and regulatory relaxation worldwide are driving this growth.
CBD is no longer...
[London, 4 July 2025] – Clearview Market Insights (CVMI) predicts that the global cell expansion market will grow from USD 20.5 billion in 2024 to USD 44.6 billion by 2031, with a compound annual growth rate (CAGR) of 11.6%. Rising demand for regenerative therapies, CAR-T cell manufacturing, and biopharmaceutical production is fueling this rapid expansion.
Cell expansion forms the...
[Boston, 4 July 2025] – Clearview Market Insights (CVMI) predicts that the global cell harvesting market will increase from USD 5.21 billion in 2024 to USD 11.68 billion by 2031, with a compound annual growth rate (CAGR) of 12.1%. The rising demand for advanced cell harvesting technologies is driven by the growth in regenerative medicine, CAR-T cell therapy, and biomanufacturing.
Cell...
[San Diego, 4 July 2025] – Clearview Market Insights (CVMI) forecasts that the global cell isolation market will expand from USD 8.29 billion in 2024 to USD 18.34 billion by 2031, with a CAGR of 11.9%. Rising demand for cell-based therapies, cancer immunotherapy, and single-cell research is fueling strong growth.
Cell isolation is central to precision medicine, supporting everything...
[Chicago, 3 July 2025] – Clearview Market Insights (CVMI) predicts that the global chlorhexidine gluconate (CHG) cloth market will increase from USD 2.01 billion in 2024 to USD 4.55 billion by 2031, with a CAGR of 12.4%. Growing demand for infection prevention in hospitals, ambulatory centers, and home care is fueling strong growth.
“CHG cloths are transforming infection...
[Geneva, 3 July 2025] – Clearview Market Insights (CVMI) projects that the global cholera vaccine market will grow from USD 430 million in 2024 to USD 1.02 billion by 2031, registering a CAGR of 12.8%. Growth is driven by increasing demand in cholera-endemic regions, expanding WHO stockpile programs, and innovations in vaccine delivery.
“Cholera vaccines are crucial tools in...
[New York, 3 July 2025] – Clearview Market Insights (CVMI) predicts that the global checkpoint inhibitors market will increase from USD 41.9 billion in 2024 to USD 98.6 billion by 2031, with a CAGR of 12.9%. Rising cancer rates, more FDA approvals, and growth in biomarker-driven precision medicine are fueling record-high demand.
Checkpoint inhibitors are transforming the oncology...
The Europe colloidal silica market is set to experience strong growth over the next decade, with market valuation projected to exceed USD 180 million by 2032, advancing at a CAGR of 5.6% between 2024 and 2032. The region's commitment to green technologies, precision manufacturing, and modern infrastructure is significantly boosting demand for colloidal silica across various industries.
Request...
The Middle East and Africa (MEA) colloidal silica market is set to witness significant growth in the coming years, with the market projected to surpass USD 58 million by 2032, growing at a CAGR of 6.1% from 2024 to 2032. Rapid urbanization, industrial diversification, and increasing adoption of advanced materials in construction, energy, and electronics are key contributors to this growth....
The North America colloidal silica market is on a strong upward trajectory, with total market valuation expected to exceed USD 235 million by 2032, growing at a CAGR of 6.2% between 2024 and 2032. The market is being driven by increasing demand across high-tech manufacturing, precision polishing, and green construction sectors.
Request Sample @...
The Latin America colloidal silica market is on track for significant growth, with market revenues projected to exceed USD 105 million by 2032, growing at a compound annual growth rate (CAGR) of 5.8% between 2024 and 2032. This expansion is being fueled by increasing usage in construction, electronics manufacturing, and precision polishing industries.
Request Sample @...
The North America Companion Diagnostics Market is projected to surge to USD 5.9 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2032. This growth is powered by the region’s strong pharmaceutical and biotechnology infrastructure, increasing demand for personalized medicine, and expanding applications of companion diagnostics (CDx) in oncology and...
Verified Profile!
Donate
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian
Portuguese (Brazil)
